Switching from high doses of pure μ-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study.
about
Switching from high doses of pure μ-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Switching from high doses of p ...... h cancer: a feasibility study.
@en
Switching from high doses of p ...... h cancer: a feasibility study.
@nl
type
label
Switching from high doses of p ...... h cancer: a feasibility study.
@en
Switching from high doses of p ...... h cancer: a feasibility study.
@nl
prefLabel
Switching from high doses of p ...... h cancer: a feasibility study.
@en
Switching from high doses of p ...... h cancer: a feasibility study.
@nl
P2093
P356
P1476
Switching from high doses of p ...... h cancer: a feasibility study.
@en
P2093
Lena Lundorff
Ole Bo Hansen
Per Rotbøll Nielsen
Torsten Jonsson
P304
P356
10.5055/JOM.2013.0166
P577
2013-07-01T00:00:00Z